NASDAQ:IDYA

Ideaya Biosciences Stock Signals

etoro logo Buy IDYA
*Your capital is at risk
$33.34
+1.20 (+3.73%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 7.921 43 days ( -27.15 % )
Last Price $33.34 3.73 %
High/ Low $31.70 - $34.61 13.38%
Chg 7 Days 7.93 % $30.89 $33.34
Chg 30 Days 13.94 % $29.26 $33.34
Chg 12 mos 25.15 % $26.64 $33.34
Trend - 3 mos 31.96 % Width: 14.08 %
Trend - 12 mos 18.22 % Width: 89.25 %
Pred. range - 3 mos $40.54 - $46.25 21.59 % - 38.71 %
Pred. range - 12 mos $20.91 - $39.58 -37.27 % - 18.72 %
Short MA avg 3 mos Buy Nov 07, 2025 - 7 days
Long MA avg 3 mos Sell Sep 12, 2025 - 47 days
Short/Long MA avg 3 mos Sell Sep 15, 2025 - 46 days
Short MA avg 12 mos Sell Oct 09, 2025 - 28 days
Long MA avg 12 mos Buy May 28, 2025 - 121 days
Short/Long MA avg 12 mos Buy Jun 09, 2025 - 113 days
Pivot Short Buy Nov 05, 2025 - 9 days
Bollinger Buy Oct 27, 2025 - 16 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT IDEAYA BIOSCIENCES INC.
IDEAYA Biosciences
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE